Back to search

Article

Single-cell Transcriptome Analysis Uncovers Heterogeneity and Key Regulators in Ibrutinib-resistant Chronic Lymphocytic Leukemia

2021-11-08

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Ibrutinib as a widely used Bruton’s tyrosine kinase inhibitor has shown outstanding value in clinical therapy for chronic lymphocytic leukemia (CLL). However, the bottleneck of ibrutinib resistance has caused widespread concerns, necessitating the exploration of novel targets. <bold>Methods</bold>Single-cell RNA sequencing (scRNA-seq) was used to characterize the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
be1fd486-e5ea-5fbd-a9bd-c8523e866cfe
DOI
10.21203/rs.3.rs-998561/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single-cell Transcriptome Analysis Uncovers Heterogeneity and Key Regulators in Ibrutinib-resistant Chronic Lymphocytic LeukemiaDOI 10.21203/rs.3.rs-998561/v1
Select a neighboring publication to make it the new centre.